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The impact of female obesity on the 
outcome of fertility treatment
ABSTRACT
The rising prevalence of obesity has had a profound impact on female reproductive health. Increased body 
mass index (BMI) is associated with ovulatory subfertility and anovulatory infertility. Overweight and obese 
women have poorer outcomes following fertility treatment. They respond poorly to clomiphene induction 
of ovulation and require higher doses of gonadotrophins for ovulation induction and superovulation. 
Ovarian stimulation for assisted reproduction produces fewer follicles resulting in the harvest of fewer 
oocytes. Fertilization rates are poorer and the embryo quality is impaired in younger women who are 
obese. Pregnancy rate in some studies is lower and there is an increased risk of early pregnancy loss. 
Weight loss regularizes menstrual cycles and increases the chance of spontaneous ovulation and conception 
in anovulatory overweight and obese women. Gradual sustained weight loss is beneficial whereas crash 
dieting is detrimental.
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l i terature search was performed on 
Medline covering a period from 1950 to 
July 2010 and EMBASE from 1980 to July 
2010, using the search terms ‘obesity’, 
‘female infertility’, ‘ovulation induction’, 
‘super ovulation IUI’, ‘donor IUI’, ‘assisted 
reproduction’, ‘IVF’, ‘ICSI’, ‘pregnancy 
rate’, ‘miscarriage rate’ and ‘live birth’. 
IMPACT OF OBESITY ON 
FERTILITY
Obesity in women has been shown to 
increase t ime to conception. [6-8] The 
relative risk of anovulatory infertility is 
2.7 (95% CI, 2.0-3.7) in women with BMI≥ 
32 kg/m2 at age 18,[9] while in ovulatory 
but subfertile woman the chance of 
spontaneous conception decreases by 
5%[10] for each unit increase in the BMI.
The mechanisms by which obesity causes 
or exacerbates subfertility are manifold. 
High BMI is associated with an increase 
in serum and follicular fluid leptin 
concentration[11] and decrease in serum 
adiponectin levels.[12] Leptin acting through 
the receptors on the theca and granulosa 
cells inhibits ovarian steroidogenesis.[13-15] 
Lower adiponectin levels are associated 
with increased circulating insulin[12] 
INTRODUCTION
Rising obesity rates present a global public 
health challenge. Approximately 1.6 
billion adults worldwide were overweight 
(BMI 25-30 kg/m2) and at least 400 million 
were obese (BMI >30 kg/m2) in 2005. These 
figures are expected to rise to 2.3 billion 
and 700 million, respectively, by 2015.[1] 
In the West, 56% of women in England[2] 
and 61% women in the United States are 
believed to be either overweight or obese.
[3] The prevalence of obesity is relatively 
low in Asian countries with 4% of Chinese 
and 0.5% of Indian women noted to be 
obese.[4] Nevertheless, in the last 20 years, 
the obesity rates have tripled in the 
developing world and 10% of all children 
across the world are overweight or obese.[5]
The World Health Organization has 
defined obesity as body mass index 
(BMI) ≥ 30 kg/m2 [Table 1]. Obesity is 
associated with cardiovascular disease, 
diabetes, osteoarthritis and malignancies 
such as colon and endometrial cancer.
[1] It is increasingly being recognized 
that this current obesity epidemic has 
also contributed to fertility problems. To 
explore the impact of obesity on fertility 
and outcome of fertility treatment, a 
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which can cause hyperandrogenaemia partly by 
inhibiting the hepatic SHBG (sex hormone binding 
globulin) production.[11] In addition, insulin acting 
via IGF1(insulin like growth factor 1) enhances LH 
mediated steroidogenesis in the theca cell system of 
the ovary and thus increases ovarian androgens.[16] 
Hyperandrogenaemia results in granulosa cell apoptosis, 
while peripheral conversion of androgens to estrogen in 
adipose tissue inhibits gonadotrophin secretion.[11] 
Obesity is also associated with polycystic ovary syndrome 
(PCOS) which is a heterogeneous condition characterized 
by oligo or anovulation, hyperandrogenism, menstrual 
irregularities and subfertilty.[17,18] Obesity which occurs in 
30-75% of women with PCOS[19] increases the magnitude 
of hormonal and metabolic dysfunction in these women.[18] 
IMPACT OF OBESITY ON FERTILITY 
TREATMENT 
To assess the impact of obesity on fertility treatment, 
we need to assess the impact of obesity on ovulation 
induction for anovulatory women, superovulation IUI 
for ovulatory subfertile women and donor insemination 
for severe male factor.
Ovulation induction
The evidence for the impact of obesity on ovulation 
induction treatment is conflicting. Obese women tend to 
respond poorly to ovulation induction using clomiphene 
citrate[20] and pregnancy rates are lower[21] in those who do.
A systematic review of 13 studies suggests that obesity and 
insulin resistance are predictors of suboptimal outcomes 
following ovulation induction using gonadotrophins. 
Women with high BMI need higher total doses of FSH 
to achieve ovulation [weighted mean difference 771 IU 
(95% CI, 700–842)]. These women also face a higher risk 
of cycle cancellation [OR 1.86 (95% CI: 1.13–3.06)] and 
are less likely to ovulate [OR 0.44 (95% CI: 0.31–0.61)].[22] 
However, in a multicenter randomized controlled trial 
involving 335 women with WHO type II anovulatory 
infertility, although those with higher BMI took longer to 
ovulate despite increased doses of gonadotrophins, rates 
of ovulation and clinical pregnancy were comparable to 
those in normal BMI women.[23] 
Superovulation IUI
In a study exploring the impact of obesity on outcomes 
of superovulation IUI treatment, there was no statistically 
significant difference in adjusted cycle fecundity and mean 
number of large follicles, following superovulation IUI 
among normal weight, overweight and obese women.[24] 
Compared to women with BMI ≥18.5<25 kg/m2, the odds 
ratio of cycle fecundity for women with BMI ≥25<30kg/
m2 was 0.70 (95%CI 0.35-1.40) and those for women with 
BMI>30 kg/m2 was 0.87 (95% CI. 0.35-2.18).[24] Obese women, 
however, had lower peak estradiol levels and required higher 
doses and longer duration of gonadotrophins injections 
compared to overweight and normal weight women.[24]
Donor insemination
Donor insemination is the treatment option for couples with 
severe male factor (azoospermia). In a study involving 1144 
women undergoing donor insemination, the authors 
concluded that pregnancy rate was 42% among women 
with BMI 20-24 kg/m2, 33% for women with BMI 25-27 kg/
m2, and 21% for women with BMI 28-36 kg/m2.[25] Thus, the 
pregnancy rates progressively decrease with increasing BMI. 
Another study concluded that the cumulative conception 
rate after 12 cycles was 48% for normal weight (BMI 20-
25) and overweight women (BMI 25-30), but only 18% for 
obese women BMI>30 kg/m2.[26] They further concluded that 
the waist hip ratio was a better predictor of outcome than 
BMI.[26] Each 0.1 unit increase in waist hip ratio resulted in 
30% decline in probability of conception per cycle (hazard 
ratio 0.706; 95% CI 0.562 to 0.887).[26]
IMPACT OF OBESITY ON ASSISTED 
REPRODUCTION
In the following section, we would like to highlight the 
impact of obesity on each individual component of in-vitro 
fertilization.
Ovarian stimulation
Gonadotrophin requirements are higher in overweight and 
obese women who have an increased incidence of poor 
ovarian response. A systematic review of IVF outcomes 
among overweight and obese women demonstrated that the 
dose of gonadotrophins required was higher in women with 
BMI of>25 kg/m2 [weighted mean difference (WMD) 210.08, 
95% CI: 149.12, 271.05] in comparison with those with BMI 
of <25 kg/m2. Gonadotrophin requirements were higher 
(WMD 361.94, 95% CI: 156.47, 567.40) in obese women 
(BMI>30 kg/m2) when compared to non obese women.[27] A 
large cohort study published after the systematic review[28] 
showed that overweight women required more ampoules of 
gonadotrophin (P<0.002), had lower peak oestradiol levels 
(P<0.001) and faced an increased risk of cycle cancellation 
due to poor follicular development (P<0.018)[28] [Table 2].
Table 1: WHO classification of obesity
BMI
Under weight <18.5
Normal weight 18.5-24.9
Over weight 25.0-29.9
Obesity class 1 30.0-34.9
Obesity class 2 35.0-39.9
Obesity class 3 40+
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Oocyte recovery
The procedure of oocyte recovery is more challenging in 
women with high BMI. Obese patients have difficult venous 
access.[29] General anesthesia can be more hazardous while 
response to conscious sedation may be erratic with a higher 
risk of hypoxaemia.[30]
Oocyte number and oocyte quality
A large cohort study has shown that in comparison with 
women of normal weight, overweight women (BMI>25<30 
kg/m2) have significantly fewer oocytes retrieved (12.98± 
6.91 vs. 14.49±7.96, P<0.001).[31] 
These findings were supported by a systematic review 
where the weighted mean difference (WMD) of the number 
of oocytes recovered in women with BMI >25 kg/m2 was 0.58 
(95% CI: 0.22, 0.94) in comparison with women with BMI 
<25 kg/m2.[27] Another study suggested that oocyte quality 
(demonstrated by number of oocytes considered suitable 
for injection or the number that fertilized) was unaffected 
by BMI.[32] 
Oocyte fertilization and embryo quality
Oocyte fertilization rates have been shown to be lower in 
morbidly obese women (59% vs. 69%; P<0.03)[33] [Table 2]. 
A large cohort study has shown that in comparison with 
women of normal weight, overweight women (BMI>25<30 
kg/m2) have lower fertilization rates (60.8±23.3 vs. 61.1±23.0, 
P<0.001), fewer cleaved embryos (7.55±4.86 vs. 8.67 ±5.90, 
P<0.001), fewer high-grade embryos (4.65±3.96 vs. 5.59±4.81, 
P<0.001) and fewer cryo preserved embryos (4.44±4.55 
vs. 5.49±5.55, P<0.001).[31] Another study demonstrated 
that embryo quality (reflected by embryo grade, embryo 
utilization and cryopreservation) in women under 35 years 
of age was poorer in those who were obese.[32] A large 
retrospective study on 6500 IVF/ICSI cycles, however, 
concluded that the embryo quality was not impaired in 
overweight and obese women.[34] This can be explained by 
the fact that the average age of women in this study was 
between 34 and 35 years and does not appear to be in conflict 
with the previous findings.
Cycle cancellation
Several studies have looked at the cycle cancellations in 
overweight and obese women. The systematic review 
by Maheshwari et al,[27] suggests that the odds of cycle 
cancellation in women with BMI of >25 kg/m2 was 1.83 
(95%CI: 1.36, 2.45) as compared to women with BMI <25 
kg/m2. However, their pooled data displayed evidence 
of significant statistical heterogeneity (P<0.05) and for 
women with BMI >30 kg/m2 the results were unable to 
confirm an increase in the risk of cycle cancellation. A recent 
study, however, demonstrated that the prevalence of poor 
responders was significantly higher among obese than non-
obese women (28.2% vs 16.9%, P<0.04)[35] [Table 2]. 
Ovarian hyperstimulation syndrome
Ovarian hyperstimulation syndrome (OHSS) is an avoidable 
complication of ovarian stimulation. A systematic review 
has not shown a statistically significant increase in the risk 
of OHSS among overweight and obese women. The authors 
of this review highlighted the fact that their conclusion 
was based on relatively small numbers of cases due to 
inconsistencies of reporting OHSS as an outcome.[27]
Implantation, pregnancy and live birth rates
A systematic review concluded that, in comparison with 
women of BMI >25, those with BMI 20–25 kg/m2 had a 
higher chance of achieving pregnancy [combined odds ratio 
= 1.40 (95% CI: 1.22, 1.60)]. The combined odds of pregnancy 
were 1.47 (95% CI: 1.20, 1.80) for a woman with a BMI 20-30 
kg/m2 as compared to women with a BMI of >30 kg/m2.[27] 
This meta-analysis of aggregated observational data was 
unable to adjust for confounders such as age, duration of 
infertility and previous pregnancy. It was also unable to 
come to any firm conclusions about the impact of obesity 
on IVF live birth rates due to insufficient evidence.[27] Some 
recent studies[28,31] have failed to confirm a direct association 
between high BMI and reduced live birth rates. Thus, we 
can conclude that while there is evidence linking obesity 
with poor implantation and pregnancy rates, more robust 
studies are needed to substantiate this [Table 2].
Early pregnancy loss
There is an increased risk of miscarriage in overweight 
and obese women after spontaneous conception, ovulation 
induction,[36] IVF[37] and oocyte donation.[38] 
A systematic review of literature showed that when 
compared with women of BMI<25, the odds of miscarriage 
in women with BMI of ≥ 25 kg/m2 were 1.33(95% CI: 1.06-
1.638). The odds of miscarriage were 1.53(95% CI: 1.27-
1.84)[27] in women with BMI≥ 30 kg/m2 when compared to 
women of BMI< 30 kg/m2. However, the authors of this 
meta-analysis were unable to adjust for confounders such as 
age and co-morbidities such as PCOS as individual patient 
Table 2: Impact of obesity on ART
Ovarian stimulation
Gonadotrophin requirement Increased
Response to stimulation Poorer
Oocyte number Reduced
Oocyte quality Unchanged
Fertilization Decreased
Embryo quality Poorer in some studies
Cycle cancellation Insufficient evidence
OHSS Insufficient evidence
Pregnancy rate Reduced in some studies
Miscarriage rate Increased 
Livebirth Insufficient evidence
OHSS - Ovarian hyperstimulation syndrome
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data were not available to them.
Another recent meta-analysis of the available evidence 
suggested that there was a significant increase in the odds 
of miscarriage in women with a BMI of ≥ 25 kg/m2 (OR1.67; 
95% CI, 1.25–2.25) following spontaneously conceived 
pregnancies as well as following ovulation induction (OR, 
5.11; 95% CI, 1.76–14.83).[39] However, there was no evidence 
for increased miscarriage rates in high BMI women who 
underwent IVF / ICSI (OR, 1.52, 95% CI, 0.88–2.61). These 
results were differing from those in the previously quoted 
systematic review due to differences in the nature of the 
included studies and the type of denominator used[39] to 
calculate the prevalence of miscarriage.
The reasons behind an increased risk of miscarriage amid 
overweight or obese women have been debated. It has been 
suggested that this is due to impaired folliculogenesis and 
poor oocyte quality in obese women. The proponents of 
this view cite a cohort study which concluded that uterine 
receptivity was unimpaired in women with increased 
BMI when hormonal support and embryo quality were 
standardized.[40] The alternative hypothesis is that 
endometrial receptivity is impaired in the overweight and 
obese women. A study involving 2656 ovum donation cycles 
with good quality embryos suggested that the ongoing 
pregnancy rate per cycle was poorer in the overweight 
and obese recipients than in the underweight and normal 
groups. Women under 25 kg/m2 had an ongoing pregnancy 
rate per cycle of 45.5%, compared with 38.3% for those with 
BMI> 25 kg/m2.[41] In another study based on 6500 IVF / ICSI 
cycles, there was no difference in the quality of embryos, but 
implantation, pregnancy, and live birth rates were poorer 
in obese women.[33]
Most authors agree that there is an increased risk of 
miscarriage in overweight and obese women after 
spontaneous conception; however, any further increase 
in risk after IVF or ICSI is debatable. The reasons of an 
increased risk of miscarriage could possibly be the higher 
prevalence of PCOS among overweight and obese women.
Due to the adverse impact of BMI on treatment outcomes, 
there have been calls for restricting publically funded 
fertility treatment to women with high BMI. The threshold 
BMI used as a cut off value for restricting access to publically 
funded fertility treatment varies around the world. Across 
the UK, there is no uniformity of practice with cut-off values 
for access to IVF varying from 30 kg/m2 to 35 kg/m2.[42] The 
NICE fertility guideline in the United Kingdom suggests 
a BMI ≤ 29 is ideal.[43] British Fertility Society guidance 
suggests that fertility treatment should be deferred until 
BMI is less than 35 kg/m2, although in those younger than 
37 years with normal FSH, weight reduction to BMI less 
than 30 kg/m2 is preferred.[44] A 5-10% weight loss has been 
recommended for overweight and obese women. 
Benefits of weight loss
Available data suggest that as little as 5%–10% weight 
loss can improve fertility outcomes.[45] Other studies have 
demonstrated that 5% weight loss results in improvement of 
endocrine parameters, such as decrease in free testosterone, 
lower fasting insulin levels and increased frequency of 
ovulation.[46] In addition, weight loss causes a significant 
reduction in central fat deposits (11%) and serum luteinizing 
hormone levels[47] with return of normal menstrual cycles 
in four out of five women.[48]
Weight loss can be achieved by lifestyle modification, 
dietary restriction, physical activity and pharmacotherapy 
with varied results. Life style modification programs 
(especially diet programs) have been shown to be associated 
with poor levels of compliance[49] and are not particularly 
suitable for women who want to conceive soon.[50] Dietary 
interventions are associated with increasing weight regain 
over time, although this can be minimized with continuing 
care.[51] Only 15% of the subjects can sustain weight loss 
successfully over time and there is a positive effect of 
group therapy, behaviour modification and active follow-
up.[52] Although enhanced reproductive function may be 
induced by caloric deficit and relatively small weight loss, 
the maintenance of reduced weight may be critical for 
reduced complications during pregnancy and birth and 
for reduction of cardiovascular and diabetic morbidity and 
mortality.[49] Rapid weight loss achieved by crash diets or 
excessive exercise is detrimental to reproductive outcomes 
during fertility treatments. A study of very low calorie 
diet resulting in 8.8% weight loss in a six week period had 
to be suspended due to its impact on oocyte quality and 
fertilization rates.[53]
In a large randomized controlled trial pharmacological 
measures like metformin, at a dose of 850 mg twice daily, 
have not been shown to affect menstrual frequency, 
body weight or insulin sensitivity, despite a fall in total 
testosterone and waist circumference.[54] There have been 
small prospective studies on the use of Orlistat in obese 
PCOS showing a degree of effectiveness; however, there 
are no large randomized controlled trials in obese subfertile 
women.[55] 
Decision making around postponement of fertility treatment 
to allow weight loss to take place needs to accommodate the 
effect of further increase in age in older women. A recent 
study demonstrated that the effect of BMI on IVF success 
was strongly influenced by age. With increasing age, the 
effect of BMI alone was attenuated such that, it became less 
influential than age, in women aged 36 years or older.[56]
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CONCLUSION
Obesity in women has impacts on fertility and fertility 
treatment. Increase in BMI reduces the chance of conception 
in ovulatory women and affects the outcome of ovulation 
induction treatment. 
Obese women undergoing IVF require higher doses of 
gonadotrophins, respond poorly to ovarian stimulation and 
have fewer oocytes harvested. Obesity is associated with 
lower fertilization rates, poor quality embryos and higher 
miscarriage rates. Weight loss in these women improves 
their reproductive outcomes; however, in order for this to 
be effective it has to be gradual and sustained.
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